-
mCherry mRNA Workflows for LNP Reporter Assays
2026-08-27
Use Cap 1, 5mCTP, and ψUTP chemistry to benchmark lipid nanoparticle delivery, map transfection performance, and obtain consistent red fluorescent protein expression. This practical guide connects a non-editing fluorescence readout with the ABE8e-COL7A1 delivery workflow reported in dystrophic epidermolysis bullosa fibroblasts, while separating delivery evidence from editing claims.
-
From Cap 1 to Translation: Smarter mCherry mRNA
2026-08-27
Cap structure, nucleotide chemistry, and assay design determine whether a fluorescent reporter becomes a dependable translational tool. This article connects red fluorescent protein mRNA engineering with lessons from bacterial redox biosensing and offers a practical framework for validating EZ Cap™ mCherry mRNA (5mCTP, ψUTP).
-
Golgi-Tracker Green for Live-Cell Golgi Imaging
2026-08-26
Golgi-Tracker Green enables selective, photostable visualization of Golgi membranes in living cells for organelle morphology, lipid trafficking, and sphingolipid studies. This practical guide pairs a reproducible labeling workflow with assay controls, troubleshooting, and a cautious translation of recent cancer research involving Golgi fragmentation.
-
AM 281: Decoding CB1–GLT-1 Signaling
2026-08-26
AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting how endocannabinoid signaling affects astrocytic GLT-1, glutamate excitotoxicity, and cognitive outcomes. This article translates recent traumatic brain injury findings into practical, causally informed assay decisions for neuropharmacology and memory impairment research.
-
BRCA2-Dependent Nascent Strand Maturation with Olaparib
2026-08-25
Milano et al. identify a BRCA1–BRCA2-dependent pathway that enables human cells to mature and repair nascent DNA strands despite PARP inhibition. The findings connect Olaparib-induced replication-associated gaps with BRCA2-dependent RAD51 activity, providing a mechanistic framework for interpreting PARP inhibitor sensitivity in DNA damage response and cancer research.
-
Protease Inhibitor Cocktail for Signaling Assays
2026-08-25
Discover how a Protease Inhibitor Cocktail EDTA-Free preserves protein complexes, phosphorylation states, and spatial signaling readouts. This article connects sample-protection strategy with new mechanistic insights into LAG-3–TCR regulation.
-
(-)-JQ1 as a Reliable BET Negative Control
2026-08-24
Learn how (-)-JQ1 (SKU A8181) strengthens viability, proliferation, and cytotoxicity assays by separating BET-dependent biology from solvent, handling, and assay-specific effects. This scenario-driven guide covers stereoisomer selection, formulation, storage, interpretation, and practical vendor evaluation.
-
SP600125: Practical JNK Inhibitor Workflows
2026-08-24
SP600125 provides a reversible, ATP-competitive way to interrogate JNK-dependent c-Jun phosphorylation, cytokine expression, inflammation, and apoptosis. This workflow-focused guide explains how to connect biochemical potency with cellular readouts while avoiding common solubility, timing, and off-target interpretation errors.
-
KG-501 and the Logic of Transcriptional Control
2026-08-23
KG-501 offers translational researchers a focused way to interrogate CREB–CBP/p300 coactivator biology while connecting transcriptional regulation with macrophage behavior and colitis-associated colorectal cancer. This thought-leadership perspective explains how to use the compound as a mechanistic probe, interpret evidence from TLR4-linked studies, and avoid overextending pharmacological results.
-
Vincristine Sulfate: Assay Design for Cancer Research
2026-08-22
Vincristine sulfate is a powerful microtubule-targeting tool for cancer research. This article presents a phenotype-to-mechanism framework for selecting assays, handling A1765 reproducibly, and interpreting evidence across leukemia, lymphoma, and solid-tumor models.
-
Cabazitaxel (XRP6258): Workflow and QC Guide
2026-08-22
Cabazitaxel is a semi-synthetic taxane derivative for studying microtubule dynamics disruption in taxane-resistant and P-glycoprotein-expressing cancer models. This guide covers solvent selection, preparation, assay setup, and QC boundaries; the compound is insoluble in water, and prepared solutions should not be stored long term.
-
CA800-PR Targets Progesterone Signaling in Breast Cancer
2026-08-21
The reference study introduces CA800-PR, a water-soluble heptamethine cyanine dye that combines tumor-associated fluorescence with suppression of progesterone receptor activity in hormone receptor-positive breast cancer models. Its reported effects connect Golgi fragmentation, selective progesterone receptor loss, apoptosis, and macrophage-associated inflammatory responses, while also highlighting important limits for clinical translation.
-
Veratridine for Chamber-Specific Cardiac Assays
2026-08-20
Veratridine is a voltage-gated sodium channel opener that can add a controlled depolarization challenge to chamber-specific cardiomyocyte models. This article explains how recent right ventricular-like hPSC-CM methodology can guide assay design, controls, and interpretation without confusing cell identity with pharmacological response.
-
Gramine: A Causal Map for Ferroptosis Assays
2026-08-20
Gramine is an indole alkaloid and ferroptosis inducer for investigating the CUL3–MTDH axis in triple-negative breast cancer research. This article translates the latest mechanistic evidence into a causal, orthogonal assay strategy rather than another dose-response guide.
-
Golgi-Tracker Green: Live-Cell Imaging Workflow
2026-08-19
Build reproducible live-cell Golgi apparatus labeling, lipid-trafficking, and sphingolipid metabolism assays with a photostable BODIPY FL-labeled C5-ceramide probe. This guide combines an executable pilot workflow with application-specific controls, troubleshooting, and a careful translation of recent Golgi-fragmentation findings into practical assay design.